These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1329697)

  • 1. A pilot study on the influence of a corticotropin (4-9) analogue on Vinca alkaloid-induced neuropathy.
    van Kooten B; van Diemen HA; Groenhout KM; Huijgens PC; Ossenkoppele GJ; Nauta JJ; Heimans JJ
    Arch Neurol; 1992 Oct; 49(10):1027-31. PubMed ID: 1329697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of neuroprotection by an ACTH (4-9) analogue. A randomized trial in patients treated with vincristine for Hodgkin's or non-Hodgkin's lymphoma.
    Koeppen S; Verstappen CC; Körte R; Scheulen ME; Strumberg D; Postma TJ; Heimans JJ; Huijgens PC; Kiburg B; Renzing-Köhler K; Diener HC
    J Cancer Res Clin Oncol; 2004 Mar; 130(3):153-60. PubMed ID: 14727106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of vinzolidine, an oral vinca alkaloid, in Hodgkin's disease and non-Hodgkin's lymphoma.
    Takasugi BJ; Jones SE; Robertone AB
    Cancer Treat Rep; 1984 Nov; 68(11):1399-401. PubMed ID: 6498855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinblastine treatment of Hodgkin's disease. Selected observations of vinca alkaloid dose schedules in man and animals.
    Lenhard RE; Owens AH; Owellen RJ
    Johns Hopkins Med J; 1974 Apr; 134(4):211-7. PubMed ID: 4821134
    [No Abstract]   [Full Text] [Related]  

  • 5. Vincristine-induced fatal neuropathy in non-Hodgkin's lymphoma.
    Tarlaci S
    Neurotoxicology; 2008 Jul; 29(4):748-9. PubMed ID: 18754106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinblastine infusion in non-Hodgkin's lymphomas: lack of total cross-resistance with vincristine.
    Jackson DV; Spurr CL; Caponera ME; White DR; Muss HB; Pavy MD; Sartiano GP; Zekan PJ; Hire EA
    Cancer Invest; 1987; 5(6):535-9. PubMed ID: 3442731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of two alkaloids derived from Vinca rosea on the malignant cells of Hodgkin's disease, lymphosarcoma and acute leukemia in vivo.
    Marmont AM; Damasio EE
    Blood; 1967 Jan; 29(1):1-21. PubMed ID: 5334796
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.
    Mathé G; Misset JL; De Vassal F; Gouveia J; Hayat M; Machover D; Belpomme D; Pico JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; De Luca L
    Cancer Treat Rep; 1978 May; 62(5):805-9. PubMed ID: 274996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vindesine: a new vinca alkaloid.
    Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
    Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced non-Hodgkin's lymphoma in a patient with Hodgkin's disease--a case report.
    Burney IA; Malik IA
    J Pak Med Assoc; 1996 Jan; 46(1):14-5. PubMed ID: 8830160
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolution of neuropathy and myopathy during intensive vincristine/corticosteroid chemotherapy for non-Hodgkin's lymphoma.
    DeAngelis LM; Gnecco C; Taylor L; Warrell RP
    Cancer; 1991 May; 67(9):2241-6. PubMed ID: 1707337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vocal fold palsy following vinca alkaloid treatment.
    Burns BV; Shotton JC
    J Laryngol Otol; 1998 May; 112(5):485-7. PubMed ID: 9747483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma.
    Yau JC; Yap YY; Buzdar AU; Hortobagyi GN; Bodey GP; Blumenschein GR
    Cancer; 1985 Jan; 55(2):337-40. PubMed ID: 3880657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas.
    Haim N; Epelbaum R; Ben-Shahar M; Yarnitsky D; Simri W; Robinson E
    Cancer; 1994 May; 73(10):2515-9. PubMed ID: 8174048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
    J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine in the treatment of lymphoma.
    Rule S; Tighe M; Davies S; Johnson S
    Hematol Oncol; 1998 Sep; 16(3):101-5. PubMed ID: 10235068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.
    Maraldo MV; Giusti F; Vogelius IR; Lundemann M; van der Kaaij MA; Ramadan S; Meulemans B; Henry-Amar M; Aleman BM; Raemaekers J; Meijnders P; Moser EC; Kluin-Nelemans HC; Feugier P; Casasnovas O; Fortpied C; Specht L;
    Lancet Haematol; 2015 Nov; 2(11):e492-502. PubMed ID: 26686259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A;
    J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine infusion in advanced non Hodgkin's lymphoma.
    Kumar L; Bajpal V; Dua H
    Indian J Cancer; 1989 Mar; 26(1):14-6. PubMed ID: 2673992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.